Non-invasive prenatal testing
Maternal blood-based screening for selected chromosome conditions, with test options chosen according to pregnancy and clinical context.
Explore NIPT →GeneMetrics helps patients and clinicians navigate prenatal screening, reproductive genetics, hereditary cancer, pharmacogenomics and specialist molecular testing — with clear pathways from question to result.
Genetic testing is most useful when the test matches the question. Our service architecture is designed to make that decision easier, then support appropriate sample collection, referral testing and result interpretation.
Maternal blood-based screening for selected chromosome conditions, with test options chosen according to pregnancy and clinical context.
Explore NIPT →Selected genetic and molecular investigations for fertility care, recurrent pregnancy loss and reproductive planning.
Explore fertility testing →Targeted and expanded screening for inherited conditions that may be relevant before or during pregnancy.
Explore carrier screening →Germline testing pathways for selected hereditary cancer syndromes, supported by clinical context and appropriate counselling.
Learn more →Genetic information that may help clinicians understand variation in response to selected medicines.
Learn more →Access to selected single-gene, panel, sequencing and molecular investigations for more complex diagnostic questions.
Learn more →A long list of assays is not the same as a good diagnostic service. GeneMetrics starts with the clinical question, then helps make the pathway understandable.
What are we trying to learn?
Choose the right test, get the sample requirements right and understand the result in context.
Start here if you are deciding whether to test, comparing options or preparing to speak to your clinician.
NIPT is a screening test that analyses cell-free DNA in a pregnant person’s blood to estimate the chance of selected chromosome conditions. It is a screening test, not a diagnostic test.
Timing depends on the specific test. Many NIPT options can be performed from around 10 weeks of pregnancy. GeneMetrics confirms eligibility for the selected test before sample collection.
No. A high-chance screening result should be discussed with the treating clinician and may require diagnostic confirmation using an appropriate invasive test.
Carrier screening looks for inherited variants associated with selected recessive or X-linked conditions. It can be considered before or during pregnancy and may help inform reproductive planning.
Yes. GeneMetrics offers access to selected reproductive and fertility-related genetic and molecular investigations. The most appropriate test depends on clinical history and the question being investigated.
GeneMetrics can facilitate hereditary cancer genetic testing when clinically appropriate. Because test selection and interpretation can be complex, results should be reviewed in clinical context and genetic counselling may be recommended.
Patients and clinicians use separate verified portal pathways.